The U.S. Department of Agriculture’s (USDA’s) Agricultural Marketing Service (AMS) is seeking comments on recommendations to update the List of Bioengineered Foods (List) under the National Bioengineered Food Disclosure Standard (NBFDS). AMS seeks comment on four issues: (1) whether it should add insect-resistant sugarcane to the List; (2) whether it should add the modifier “virus-resistant”
Biotechnology
AMS Issues Final Guidance on Detectability Testing and Validation of Refining Processes Under the National Bioengineered Food Disclosure Standard
By Martin Hahn, Veronica Colas & Leigh Barcham on
The U.S. Department of Agriculture’s (USDA’s) Agricultural Marketing Service (AMS) issued two final guidance documents providing industry stakeholders with instructions on how to implement certain requirements of the National Bioengineered Food Disclosure Standard (NBFDS). The agency’s Guidance to Ensure Acceptable Validation of a Refining Process outlines steps for validating that a refining process makes modified…
Webinar: Regulating your way into the American market
By Gary Kushner on
Posted in Biotechnology
Regulation is a crucial aspect that must be taken into consideration when thinking about creating a new start-up and when entering new markets.
Join GrowingIL’s next webinar on June 24, 2020, where Hogan Lovells partner Gary Jay Kushner will shed light on Agtech regulation in the U.S. and specifically in the fields of biotechnology, plant…
USDA’s AMS Issues Final Rule on National Bioengineered Food Disclosure Standard
By Martin Hahn & Veronica Colas on
Yesterday the U.S. Department of Agriculture’s (USDA’s) Agricultural Marketing Service (AMS) released its final rule implementing the National Bioengineered Food Disclosure Standard (NBFDS) passed by Congress in July 2016. In this post we summarize the top ten key highlights of the final rule.
FDA Releases Plant and Animal Biotechnology Innovation Action Plan
By Joe Levitt & Mary Lancaster on
The U.S. Food and Drug Administration (FDA) recently released its Plant and Animal Biotechnology Innovation Action Plan (“Action Plan”). The Action Plan provides an overview of the key priorities FDA expects to pursue through 2020 to support innovation in plant and animal biotechnology. As highlighted in FDA Commissioner Gottlieb’s statement, the agency is committed to…